Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. scores highest on Torque (53) and lowest on Earnings (28). Its PosiPenta is 36.56 out of 100, weaker than most similar companies.
On the Penta Grid this week, Monte Rosa Therapeutics, Inc. is Grid #637 of 837 in the Healthcare sector in United States, and Grid #3,183 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 36.56 | 31 | 28 | 31 | 53 | 39 |
| Jade Biosciences, Inc. | 44.78 | 30 | 23 | 50 | 80 | 41 |
| ArriVent BioPharma, Inc. | 39.97 | 26 | 20 | 46 | 65 | 43 |
| SpyGlass Pharma, Inc. | 48.43 | 19 | 23 | 72 | 77 | 51 |
| MeiraGTx Holdings plc | 55.72 | 57 | 43 | 60 | 64 | 56 |
| Integra LifeSciences Holdings Corporation | 58.12 | 40 | 87 | 65 | 42 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.57 |
| P/B ratio | 1.71 |
EEarnings
| Trailing EPS | ₹-165.75 |
| Forward EPS | ₹-174.93 |
NNitro
| Price | 922.52 |
| 52-week high | 2440.80 |
| 52-week low | 847.04 |
| Fall from 52-week high | 62.2% |
TTorque
| Return on equity (ROE) | -42.66% |
| Debt-to-equity | 0.08 |
AAnchor
| Beta (price swings) | 1.37 |
| Market cap | ₹7,870 Cr |
| Insider holding | 0.56% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Monte Rosa Therapeutics, Inc.'s PosiPenta score?
Monte Rosa Therapeutics, Inc.'s PosiPenta is 36.56 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Monte Rosa Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Monte Rosa Therapeutics, Inc. is Grid #637 of 837 in the Healthcare sector in United States, and Grid #3,183 of 4,000 in United States.
Which PosiPenta pillar is strongest for Monte Rosa Therapeutics, Inc.?
Torque (durability), with a score of 53 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Monte Rosa Therapeutics, Inc.?
Earnings (growth), with a score of 28 out of 100: weaker than most similar companies.
Has Monte Rosa Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.18 points, from 33.38 to 36.56.
PositoAI is for research and education only and is not investment advice.